{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:22:31Z","timestamp":1782300151041,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015726","name":"Oncology Nursing Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015726","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11764-021-01081-z","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T14:03:08Z","timestamp":1631714588000},"page":"882-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-5068","authenticated-orcid":false,"given":"Robert","family":"Knoerl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Giobbie-Hurder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Berfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Meyerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexi A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Ligibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","volume":"157","author":"L Ventzel","year":"2016","unstructured":"Ventzel L, Jensen AB, Jensen AR, Jensen TS, Finnerup NB. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel. Pain. 2016;157:560\u20138.","journal-title":"Pain"},{"key":"1081_CR2","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","volume":"35","author":"KM Winters-Stone","year":"2017","unstructured":"Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S, et al. Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol. 2017;35:2604\u201312.","journal-title":"J Clin Oncol"},{"key":"1081_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","volume":"73","author":"NA Kolb","year":"2016","unstructured":"Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S, et al. The Association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol. 2016;73:860.","journal-title":"JAMA Neurol"},{"key":"1081_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.12788\/jcso.0086","volume":"12","author":"A Beijers","year":"2014","unstructured":"Beijers A, Mols F, Dercksen W, Driessen C, Vreugdenhil G. Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy. J community Support Oncol. 2014;12:401\u20136.","journal-title":"J community Support Oncol"},{"key":"1081_CR5","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1007\/s00520-016-3329-5","volume":"24","author":"NR Zanville","year":"2016","unstructured":"Zanville NR, Nudelman KNH, Smith DJ, Von Ah D, McDonald BC, Champion VL, et al. Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer Springer. 2016;24:4779\u201389.","journal-title":"Support Care Cancer Springer"},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pmn.2018.12.010","volume":"20","author":"R Knoerl","year":"2019","unstructured":"Knoerl R, Chornoby Z, Smith EML. Corrigendum to \u2018Estimating the frequency, severity, and clustering of\u00a0SPADE symptoms in chronic painful chemotherapy-induced peripheral neuropathy\u2019 Pain Management Nursing 2018;19(4):354\u2013365. Pain Manag Nurs. 2019;20:88.","journal-title":"Pain Manag Nurs"},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pmn.2018.01.001","volume":"19","author":"R Knoerl","year":"2018","unstructured":"Knoerl R, Chornoby Z, Smith EML. Estimating the frequency, severity, and clustering of SPADE symptoms in chronic painful chemotherapy-induced peripheral neuropathy. Pain Manag Nurs Elsevier. 2018;19:354\u201365.","journal-title":"Pain Manag Nurs Elsevier"},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309:1359\u201367.","journal-title":"JAMA"},{"key":"1081_CR9","doi-asserted-by":"publisher","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 2020;38(28):3325\u201348. https:\/\/doi.org\/10.1200\/JCO.20.01399","DOI":"10.1200\/JCO.20.01399"},{"key":"1081_CR10","doi-asserted-by":"publisher","first-page":"E134","DOI":"10.1188\/18.CJON.E134-E140","volume":"22","author":"R Knoerl","year":"2018","unstructured":"Knoerl R, Bridges C, Smith G, Yang J, Kanzawa-Lee G, Smith E. Chemotherapy-induced peripheral neuropathy: use of an electronic care planning system to improve adherence to recommended assessment and management practices. Clin J Oncol Nurs. 2018;22:E134\u201340.","journal-title":"Clin J Oncol Nurs"},{"key":"1081_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1200\/JOP.18.00428","volume":"14","author":"NU Lin","year":"2018","unstructured":"Lin NU, Bichkoff H, Hassett MJ. Increasing burden of prior authorizations in the delivery of oncology care in the United States. J Oncol Pract. 2018;14:525\u20138.","journal-title":"J Oncol Pract"},{"key":"1081_CR12","doi-asserted-by":"publisher","unstructured":"Shah A, Hoffman EM, Mauermann ML, et al. Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort. J Neurol Neurosurg Psychiatry. 2018;89(6):636\u201341. https:\/\/doi.org\/10.1136\/jnnp-2017-317215","DOI":"10.1136\/jnnp-2017-317215"},{"key":"1081_CR13","doi-asserted-by":"publisher","unstructured":"Wieland LS, Skoetz N, Pilkington K, Vempati R, D'Adamo CR, Berman BM. Yoga treatment for chronic non-specific low back pain. Cochrane Database Syst Rev. 2017;1(1):CD010671. https:\/\/doi.org\/10.1002\/14651858.CD010671.pub2","DOI":"10.1002\/14651858.CD010671.pub2"},{"key":"1081_CR14","doi-asserted-by":"publisher","unstructured":"Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev. 2017;1(1):CD010802. https:\/\/doi.org\/10.1002\/14651858.CD010802.pub2","DOI":"10.1002\/14651858.CD010802.pub2"},{"key":"1081_CR15","doi-asserted-by":"publisher","unstructured":"Danhauer SC, Addington EL, Cohen L, et al. Yoga for symptom management in oncology: A review of the evidence base and future directions for research. Cancer. 2019;125(12):1979\u201389. https:\/\/doi.org\/10.1002\/cncr.31979","DOI":"10.1002\/cncr.31979"},{"key":"1081_CR16","doi-asserted-by":"publisher","unstructured":"Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010;149(2):177\u201393. https:\/\/doi.org\/10.1016\/j.pain.2010.02.018","DOI":"10.1016\/j.pain.2010.02.018"},{"key":"1081_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","volume":"113","author":"RH Dworkin","year":"2005","unstructured":"Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9\u201319.","journal-title":"Pain"},{"key":"1081_CR18","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129\u201338.","journal-title":"Ann Acad Med Singapore"},{"key":"1081_CR19","first-page":"S3","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care NIH Public Access. 2007;45:S3-11.","journal-title":"Med Care NIH Public Access"},{"key":"1081_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2010.04.025","volume":"150","author":"D Amtmann","year":"2010","unstructured":"Amtmann D, Cook KF, Jensen MP, Chen W-H, Choi S, Revicki D, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150:173\u201382.","journal-title":"Pain"},{"key":"1081_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15402002.2012.636266","volume":"10","author":"L Yu","year":"2012","unstructured":"Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, et al. Development of short forms from the PROMISTM Sleep Disturbance and Sleep-Related Impairment Item Banks. Behav Sleep Med. 2012;10:6\u201324.","journal-title":"Behav Sleep Med"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/pme.12537","volume":"15","author":"K Kroenke","year":"2014","unstructured":"Kroenke K, Yu Z, Wu J, Kean J, Monahan PO. Operating characteristics of PROMIS four-item depression and anxiety scales in primary care patients with chronic pain. Pain Med. 2014;15:1892\u2013901.","journal-title":"Pain Med"},{"key":"1081_CR23","doi-asserted-by":"crossref","unstructured":"Bartlett SJ, Orbai A-M, Duncan T, DeLeon E, Ruffing V, Clegg-Smith K, et al. Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. Zhang C, editor. PLoS One. 2015;10:e0138543.","DOI":"10.1371\/journal.pone.0138543"},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s11136-015-0992-9","volume":"24","author":"RE Jensen","year":"2015","unstructured":"Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, et al. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res NIH Public Access. 2015;24:2333\u201344.","journal-title":"Qual Life Res NIH Public Access"},{"key":"1081_CR25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41:1135\u20139.","journal-title":"Eur J Cancer"},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","volume":"22","author":"EML Smith","year":"2013","unstructured":"Smith EML, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Qual Life Res. 2013;22:2787\u201399.","journal-title":"Qual Life Res"},{"key":"1081_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1188\/17.ONF.580-588","volume":"44","author":"EM Lavoie Smith","year":"2017","unstructured":"Lavoie Smith EM, Haupt R, Kelly JP, Lee D, Kanzawa-Lee G, Knoerl R, et al. The content validity of a chemotherapy-induced peripheral neuropathy patient-reported outcome measure. Oncol Nurs Forum. 2017;44:580\u20138.","journal-title":"Oncol Nurs Forum"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","volume":"285","author":"D Moher","year":"2001","unstructured":"Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Med Assoc. 2001;285:1987\u201391.","journal-title":"J Am Med Assoc"},{"key":"1081_CR29","doi-asserted-by":"publisher","unstructured":"Latte-Naor S, Mao JJ. Putting integrative oncology into practice: concepts and approaches. J Oncol Pract. 2019;15(1):7\u201314. https:\/\/doi.org\/10.1200\/JOP.18.00554","DOI":"10.1200\/JOP.18.00554"},{"key":"1081_CR30","doi-asserted-by":"publisher","unstructured":"Knoerl R, Phillips CS, Berfield J, et al. Lessons learned from the delivery of virtual integrative oncology interventions in clinical practice and research during the COVID-19 pandemic. Support Care Cancer. 2021;29(8):4191\u20134. https:\/\/doi.org\/10.1007\/s00520-021-06174-0","DOI":"10.1007\/s00520-021-06174-0"},{"key":"1081_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jclinepi.2010.11.018","volume":"64","author":"KJ Yost","year":"2011","unstructured":"Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011;64:507\u201316.","journal-title":"J Clin Epidemiol"},{"key":"1081_CR32","doi-asserted-by":"publisher","unstructured":"Bao T, Zhi I, Baser R, et al. Yoga for chemotherapy-induced peripheral neuropathy and fall risk: a randomized controlled\ntrial. JNCI Cancer Spectr. 2020;4(6):pkaa048. https:\/\/doi.org\/10.1093\/jncics\/pkaa048","DOI":"10.1093\/jncics\/pkaa048"},{"key":"1081_CR33","doi-asserted-by":"crossref","unstructured":"Park CL, Groessl E, Maiya M, Sarkin A, Eisen S V., Riley K, et al. Comparison groups in yoga research: a systematic review and critical evaluation of the literature. Complement. Ther. Med. Churchill Livingstone; 2014 [cited 2021 Feb 8]. p. 920\u20139.","DOI":"10.1016\/j.ctim.2014.08.008"},{"key":"1081_CR34","doi-asserted-by":"publisher","unstructured":"Selvy M, Pereira B, Kerckhove N, et al. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists\u2019 professional practices. Support Care Cancer. 2021;29(7):4033\u201343. https:\/\/doi.org\/10.1007\/s00520-020-05928-6","DOI":"10.1007\/s00520-020-05928-6"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-021-01081-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:13:14Z","timestamp":1744193594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-021-01081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s11764-021-01081-z","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"4 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Dana-Farber\/Harvard Cancer Center Office for Human Research Studies (18\u2013578).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RK has received personal fees (consulting) from Strategy Inc, Spark Healthcare, and System Analytic; and serves on the scientific advisory board of Wellium. JM has received institutional research funding from Boston Biomedical, has served as an advisor\/consultant to COTA Healthcare, and has served on a grant review panel for the National Comprehensive Cancer Network funded by Taiho Pharmaceutical.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}